APOTHEEK GRIMBERGEN: what changed
APOTHEEK GRIMBERGEN
Largest movements
- Stocks and contracts +€95,549
up €95,549 (+22.3%), from €429,047 to €524,596
- Cash -€17,300
down €17,300 (-62.5%), from €27,701 to €10,401
mainly Stocks and contracts (-€95,549) and Investment in fixed assets (net) (-€39,320)
- Tangible fixed assets -€16,405
down €16,405 (-3.1%), from €534,397 to €517,992
of which Furniture and vehicles: -€10,953
- Other debts +€37,419
up €37,419 (+24.4%), from €153,470 to €190,889
- Trade debts +€31,535
up €31,535 (+26.3%), from €119,991 to €151,526
- Gross operating margin -€53,080
down €53,080 (-25.0%), from €212,677 to €159,597
- Financial charges -€18,700
down €18,700 (-52.3%), from €35,778 to €17,079
- Depreciation +€3,461
up €3,461 (+6.2%), from €56,265 to €59,725
- Staff costs +€3,012
up €3,012 (+3.9%), from €76,661 to €79,674
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,087,513 | €1,151,873 | +€64,360 | +5.9% |
| Fixed assets | 21/28 | €557,064 | €536,659 | -€20,405 | -3.7% |
| Intangible fixed assets | 21 | €17,667 | €13,667 | -€4,000 | -22.6% |
| Tangible fixed assets | 22/27 | €534,397 | €517,992 | -€16,405 | -3.1% |
| Plant, machinery and equipment | 23 | €494,882 | €489,429 | -€5,453 | -1.1% |
| Furniture and vehicles | 24 | €39,515 | €28,562 | -€10,953 | -27.7% |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €530,449 | €615,215 | +€84,765 | +16.0% |
| Stocks and contracts in progress | 3 | €429,047 | €524,596 | +€95,549 | +22.3% |
| Stocks | 30/36 | €429,047 | €524,596 | +€95,549 | +22.3% |
| Amounts receivable within one year | 40/41 | €65,640 | €75,348 | +€9,708 | +14.8% |
| Trade receivables | 40 | €48,578 | €55,630 | +€7,053 | +14.5% |
| Other amounts receivable | 41 | €17,063 | €19,718 | +€2,655 | +15.6% |
| Cash at bank and in hand | 54/58 | €27,701 | €10,401 | -€17,300 | -62.5% |
| Deferred charges and accrued income | 490/1 | €8,061 | €4,869 | -€3,192 | -39.6% |
| Total equity and liabilities | 10/49 | €1,087,513 | €1,151,873 | +€64,360 | +5.9% |
| Equity | 10/15 | €150,464 | €152,784 | +€2,320 | +1.5% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €144,264 | €146,584 | +€2,320 | +1.6% |
| Amounts payable | 17/49 | €937,049 | €999,089 | +€62,040 | +6.6% |
| Amounts payable after more than one year | 17 | €591,213 | €581,468 | -€9,745 | -1.6% |
| Financial debts | 170/4 | €591,213 | €581,468 | -€9,745 | -1.6% |
| Amounts payable within one year | 42/48 | €344,869 | €413,123 | +€68,254 | +19.8% |
| Current portion of amounts payable after more than one year | 42 | €62,613 | €63,001 | +€388 | +0.6% |
| Trade debts | 44 | €119,991 | €151,526 | +€31,535 | +26.3% |
| Suppliers | 440/4 | €119,991 | €151,526 | +€31,535 | +26.3% |
| Taxes, remuneration and social security | 45 | €8,794 | €7,706 | -€1,088 | -12.4% |
| Taxes | 450/3 | €1,142 | - | -€1,142 | |
| Remuneration and social security | 454/9 | €7,652 | €7,706 | +€54 | +0.7% |
| Other amounts payable | 47/48 | €153,470 | €190,889 | +€37,419 | +24.4% |
| Accrued charges and deferred income | 492/3 | €968 | €4,498 | +€3,531 | +365% |
| Remuneration, social security and pensions | 62 | €76,661 | €79,674 | +€3,012 | +3.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €56,265 | €59,725 | +€3,461 | +6.2% |
| Other operating charges | 640/8 | €968 | €998 | +€31 | +3.2% |
| Gross operating margin | 9900 | €212,677 | €159,597 | -€53,080 | -25.0% |
| Operating profit (loss) | 9901 | €78,783 | €19,199 | -€59,584 | -75.6% |
| Financial income | 75/76B | €160 | €437 | +€277 | +173% |
| Recurring financial income | 75 | €160 | €437 | +€277 | +173% |
| Financial charges | 65/66B | €35,778 | €17,079 | -€18,700 | -52.3% |
| Recurring financial charges | 65 | €35,778 | €17,079 | -€18,700 | -52.3% |
| Profit (loss) for the period before taxes | 9903 | €43,165 | €2,557 | -€40,608 | -94.1% |
| Income taxes | 67/77 | €146 | €237 | +€92 | +63.1% |
| Profit (loss) for the period | 9904 | €43,019 | €2,320 | -€40,700 | -94.6% |
| Profit (loss) for the period to be appropriated | 9905 | €43,019 | €2,320 | -€40,700 | -94.6% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.